Pelvalon today announced the publication in BMJ Innovations of peer-reviewed research from the original proof-of-concept study. This first-in-woman study provided the initial demonstration of the key design principles of Eclipse: that a non-surgical vaginal insert can effectively and comfortably control the bowel.
Eric R. Sokol, M.D., Co-Director of Urogynecology and Pelvic Reconstructive Surgery and Associate Professor at Stanford University School of Medicine, was the principal investigator for this early study of the first vaginal insert for bowel control. “This feasibility work was an important proof-of-concept for the Eclipse System, demonstrating that a vaginal insert could successfully occlude the rectum and, importantly, was well tolerated and comfortable for the women who wore it,” said Dr. Sokol. “These findings lead to clinical development of Eclipse, which is now helping women across the United States suffering from this embarrassing condition.”
BMJ Innovations highlights the latest medical devices, technologies, processes and systems that improve patient care, focusing on clinical innovation.